MX2023012830A - Compuestos de ácido acético pirrolidinilo y tetrahidro-2h-piranilo sustituidos con triazol-piridina novedosos como antagonistas de lpa. - Google Patents

Compuestos de ácido acético pirrolidinilo y tetrahidro-2h-piranilo sustituidos con triazol-piridina novedosos como antagonistas de lpa.

Info

Publication number
MX2023012830A
MX2023012830A MX2023012830A MX2023012830A MX2023012830A MX 2023012830 A MX2023012830 A MX 2023012830A MX 2023012830 A MX2023012830 A MX 2023012830A MX 2023012830 A MX2023012830 A MX 2023012830A MX 2023012830 A MX2023012830 A MX 2023012830A
Authority
MX
Mexico
Prior art keywords
pyranyl
tetrahydro
acetic acid
triazole
novel
Prior art date
Application number
MX2023012830A
Other languages
English (en)
Spanish (es)
Inventor
Ping Chen
Hongjian Zhang
Fei Jiang
Peihua Sun
Zhenwei Cai
Original Assignee
Viva Star Biosciences Suzhou Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viva Star Biosciences Suzhou Co Ltd filed Critical Viva Star Biosciences Suzhou Co Ltd
Publication of MX2023012830A publication Critical patent/MX2023012830A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2023012830A 2021-04-30 2022-04-28 Compuestos de ácido acético pirrolidinilo y tetrahidro-2h-piranilo sustituidos con triazol-piridina novedosos como antagonistas de lpa. MX2023012830A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2021091510 2021-04-30
PCT/US2022/026832 WO2022232459A1 (en) 2021-04-30 2022-04-28 Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists

Publications (1)

Publication Number Publication Date
MX2023012830A true MX2023012830A (es) 2024-01-19

Family

ID=81748636

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023012830A MX2023012830A (es) 2021-04-30 2022-04-28 Compuestos de ácido acético pirrolidinilo y tetrahidro-2h-piranilo sustituidos con triazol-piridina novedosos como antagonistas de lpa.

Country Status (10)

Country Link
US (1) US20250230140A1 (https=)
EP (1) EP4330249A1 (https=)
JP (1) JP2024517769A (https=)
KR (1) KR20240044386A (https=)
CN (1) CN117751106A (https=)
AU (1) AU2022264579A1 (https=)
CA (1) CA3218258A1 (https=)
IL (1) IL308035A (https=)
MX (1) MX2023012830A (https=)
WO (1) WO2022232459A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023109878A1 (zh) * 2021-12-15 2023-06-22 武汉人福创新药物研发中心有限公司 三氮唑类lpar1拮抗剂及其用途
WO2025051267A1 (zh) * 2023-09-08 2025-03-13 西藏海思科制药有限公司 一种lpar1拮抗剂及其用途
WO2025051266A1 (zh) * 2023-09-08 2025-03-13 西藏海思科制药有限公司 杂芳环衍生物的lpar1拮抗剂及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019126084A1 (en) * 2017-12-19 2019-06-27 Bristol-Myers Squibb Company Isoxazole o-linked carbamoyl cyclohexyl acids as lpa antagonists
JP7208240B2 (ja) * 2017-12-19 2023-01-18 ブリストル-マイヤーズ スクイブ カンパニー Lpaアンタゴニストとしてのシクロヘキシル酸トリアゾールアジン
ES2946657T3 (es) * 2018-09-18 2023-07-24 Bristol Myers Squibb Co Acidos ciclopentílicos como antagonistas de LPA
CN111434655A (zh) * 2019-01-15 2020-07-21 武汉朗来科技发展有限公司 溶血磷脂酸受体拮抗剂及其制备方法
WO2020257135A1 (en) * 2019-06-18 2020-12-24 Bristol-Myers Squibb Company Triazole carboxylic acids as lpa antagonists
WO2022034568A1 (en) * 2020-08-11 2022-02-17 Viva Star Biosciences Limited Triazole-pyridinyl substituted azacyclohexyl acetic acid compounds as lpa receptor antagonists

Also Published As

Publication number Publication date
WO2022232459A1 (en) 2022-11-03
KR20240044386A (ko) 2024-04-04
EP4330249A1 (en) 2024-03-06
CN117751106A (zh) 2024-03-22
CA3218258A1 (en) 2022-11-03
IL308035A (en) 2023-12-01
AU2022264579A1 (en) 2023-12-14
JP2024517769A (ja) 2024-04-23
US20250230140A1 (en) 2025-07-17

Similar Documents

Publication Publication Date Title
MX2023001812A (es) Compuestos del acido azociclohexil acetico sustituidos por triazol-piridinilo como antagonistas del receptor lpa.
MX2023012830A (es) Compuestos de ácido acético pirrolidinilo y tetrahidro-2h-piranilo sustituidos con triazol-piridina novedosos como antagonistas de lpa.
HN2011000341A (es) Compuestos derivados de sulfonamidas, composiciones farmaceuticos y proceso de preparacion de los mismos
UY32543A (es) Análogos de isoxazol-3(2h)-ona como agentes terapéuticos
CO6501183A2 (es) Piperidinas sustituidas como antagonistas de ccr3
CO6480918A2 (es) Antagonistas policíclicos de receptores de ácido lisofosfatídico.
ECSP11011512A (es) Enantiómeros de compuestos de espirooxindol y sus usos como agentes terapéuticos
CU20130082A7 (es) 1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr
CO6771417A2 (es) Antagonistas del receptor de ácido lisofosfatidico y su uso en el tratamiento de fibrosis
CO6551729A2 (es) Moduladores alostericos positivos de receptores de m1 de quinolina amida
MX366041B (es) Compuestos antihelmínticos y composiciones y método de uso de los mismos.
DOP2014000012A (es) Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa
ECSP13012494A (es) Inhibidores de oxadiazol de la producción de leucotrieno.
UY34964A (es) Derivados de cromano como inhibidores del receptor transitorio potencial de la melastatina 8 (trpm8)
UY30533A1 (es) Acetamidas n-{1-[4(1-ciano-1-metil)fenil]etil}sustituidas derivadas del acido 2-(1h-bencimidazol-1il) acético
PE20181446A1 (es) Derivados de 5-etil-4-metil-pirazol-3-carboxamida con actividad como de taar
MX2023007265A (es) Inhibidores de cdk y su uso como productos farmacéuticos.
MX2021011576A (es) Nuevos compuestos y composiciones farmaceuticas de los mismos para el tratamiento de trastornos inflamatorios.
MX2021011574A (es) Nuevos compuestos y composiciones farmaceuticas de los mismos para el tratamiento de trastornos inflamatorios.
PY22111032A (es) Inhibidores de dhodh que contienen un bioisostero de acido carboxilico
PH12013500330A1 (en) Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor
CO2023013700A2 (es) Compuestos para regular la inmunidad entrenada y métodos para usarlos
DOP2022000203A (es) 3-fenoxiazetidin-1-il-pirazinas sustituidas con actividad antagonista gpr52
MX2024010344A (es) Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor de lpa
UY35785A (es) Derivados de piperazina sustituidos como moduladores del transportador de la glicina-1 (glyt1)